Altshuler Shaham’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-430
Closed -$28.9K 319
2023
Q2
$28.9K Buy
+430
New +$26.2K ﹤0.01% 246
2022
Q4
Sell
-1,198
Closed -$62K 542
2022
Q3
$62K Buy
+1,198
New +$59.9K ﹤0.01% 188
2021
Q4
Sell
-858
Closed -$46K 601
2021
Q3
$46K Buy
858
+65
+8% +$3.66K ﹤0.01% 434
2021
Q2
$48K Sell
793
-1,323
-63% -$70.3K ﹤0.01% 437
2021
Q1
$103K Buy
2,116
+1,123
+113% +$52.6K ﹤0.01% 217
2020
Q4
$40K Buy
+993
New +$35.5K ﹤0.01% 295
2020
Q1
Sell
-389
Closed -$14K 540
2019
Q4
$14K Buy
389
+93
+31% +$3.21K ﹤0.01% 302
2019
Q3
$10K Buy
+296
New +$9.46K ﹤0.01% 280

Other funds holding LMAT

Altshuler Shaham's LMAT Position: Q3 2023 in Review

Altshuler Shaham sold out of LeMaitre Vascular (LMAT) in Q3 2023, closing a stake of 430 shares — an estimated $28.9K sold.

Altshuler Shaham first reported a position in LMAT in Q3 2019 and held it in 8 quarters. The position peaked at $103K in Q1 2021. 220 funds tracked by Wall St. Rank hold LMAT as of Q3 2023.

  • Altshuler Shaham reported no remaining LeMaitre Vascular position as of Q3 2023 after selling out during the quarter.
  • Altshuler Shaham sold 430 LeMaitre Vascular shares in Q3 2023, an estimated $28.9K.
  • Altshuler Shaham first reported a position in LeMaitre Vascular in Q3 2019 and held it in 8 quarters.
  • Altshuler Shaham's LeMaitre Vascular position peaked at $103K in Q1 2021.
  • 220 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2023.

Based on Altshuler Shaham's 13F filing for Q3 2023, filed 13 Nov 2023.